Next Generation Sequencing Market by Type (Consumables, NGS Platform, Software), Sequencing Type (Whole Genome, Targeted), Technology (Sequencing by Synthesis, Sequencing by Ligation), Application (Clinical, Research), End User - Global Forecasts to 2025

  • Report ID:MRHC - 104342
  • Pages: 253
  • Oct 2019
  • Formats*: PDF
  • Category: Healthcare

1. Introduction
    1.1. Market Ecosystem
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Secondary Research
    2.2. Primary Research

3. Executive Summary

4. Market Insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Technological Advancements in Sequencing Procedures
                     4.2.1.2. Surge in Genome Mapping Programs
                     4.2.1.3. Increase in Drug Discovery Platforms Demanding NGS Technology
           4.2.2. Restraints
                     4.2.2.1. Lack of Skilled Professionals
                     4.2.2.2. Ethical & Legal Issues Related to NGS Based Diagnosis
           4.2.3. Opportunities
                     4.2.3.1. Growing Government Initiatives for Large-Scale Genomic Sequencing Projects
                     4.2.3.2. Emergence of Cloud Computing as a Potential Data Management Service
           4.2.4. Challenges
                     4.2.4.1. Sample Quality and Difficulty in Management of Large Volume of Sequencing Data
                     4.2.4.2. Interpretation of Complex Data
           4.2.5. Trends
                     4.2.5.1. Partnerships and Collaborations by Manufacturers for Technological Advancements in NGS
                     4.2.5.2. Development of Portable Sequencing Technologies

5. Next Generation Sequencing Market, by Type
    5.1. Introduction
    5.2. Consumables
           5.2.1. Sample Preparation Consumables
                     5.2.1.1. DNA Extraction and Amplification
                     5.2.1.2. Library Preparation & Target Enrichment
                     5.2.1.3. Quality Control
            5.2.2. Other Consumables
     5.3. NGS Platforms/Instruments
            5.3.1. Illumina
                      5.3.1.1. MiniSeq Series
                      5.3.1.2. NovaSeq
                      5.3.1.3. NextSeq
                      5.3.1.4. MiSeq
                      5.3.1.5. iSeq
            5.3.2. Thermo Fisher Scientific
                      5.3.2.1. Ion Proton
                      5.3.2.2. Ion PGM
                      5.3.2.3. Ion S5 & S5 Xl
            5.3.3. Pacific Biosciences
                      5.3.3.1. PacBio RS II
                      5.3.3.2. PacBio Sequel
            5.3.4. Oxford Nanopore Technologies
            5.3.5. Other NGS Instruments
 5.4. Software
 5.5. Services

6. Next Generation Sequencing Market, by Sequencing Type
    6.1. Introduction
    6.2. Whole Genome Sequencing
    6.3. Whole Exome Sequencing
    6.4. Targeted Genome Sequencing
    6.5. Others

7. Next Generation Sequencing Market, by Technology
    7.1. Introduction
    7.2. Sequencing by Synthesis (SBS)
    7.3. Ion Semiconductor Sequencing
    7.4. Sequencing by Ligation (SBL)
    7.5. Single-Molecule Real-Time (SMRT) Sequencing
    7.6. Nanopore Sequencing
    7.7. Others

8. Next Generation Sequencing Market, by Application
    8.1. Introduction
    8.2. Clinical Application
           8.2.1. Oncology
           8.2.2. Reproductive Health Diagnostics
                     8.2.2.1. Non-Invasive Prenatal Testing (NIPT)
                     8.2.2.2. Carrier Screening
                     8.2.2.3. In-Vitro Fertilization
                     8.2.2.4. Newborn Screening
           8.2.3. Cardiovascular Diseases
           8.2.4. Others
    8.3. Research Applications
           8.3.1. Drug Discovery
           8.3.2. Agriculture & Animal Research
           8.3.3. Others

9. Next Generation Sequencing Market, by End User
    9.1. Introduction
    9.2. Clinical Diagnostic Laboratories
    9.3. Academic Institutes & Research Centers
    9.4. Pharmaceutical & Biotechnology Companies
    9.5. Other End Users

10. Next Generation Sequencing Market, Geography Analysis
      10.1. Introduction
      10.2. North America
              10.2.1. U.S.
              10.2.2. Canada
      10.3. Europe
              10.3.1. Germany
              10.3.2. France
              10.3.3. U.K.
              10.3.4. Italy
              10.3.5. Spain
              10.3.6. Rest of Europe
      10.4. Asia-Pacific
              10.4.1. Japan
              10.4.2. China
              10.4.3. India
              10.4.4. Rest of Asia-Pacific
      10.5. Latin America
      10.6. Middle East & Africa

11. Competitive Landscape
      11.1. Competitive Growth Strategies
      11.2. Competitive
      11.3. Market Share Analysis

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments)
      12.1. Illumina, Inc.
      12.2. Agilent Technologies, Inc.
      12.3. Bio-Rad Laboratories, Inc.
      12.4. Thermo Fisher Scientific Inc.
      12.5. Qiagen N.V.
      12.6. PerkinElmer, Inc.
      12.7. F. Hoffmann-La Roche AG
      12.8. 10x Genomics, Inc.
      12.9. Pacific Biosciences of California, Inc.
      12.10. Oxford Nanopore Technologies Ltd
      12.11. Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
      12.12. GenapSys, Inc.
      12.13. New England Biolabs, Inc.
      12.14. PierianDx
      12.15. BGI Genomics (BGI) (A Subsidiary of BGI Group)

13. Appendix
      13.1. Questionnaire
      13.2. Available Customization

List of Tables

Table 1 Currency Conversion Rate
Table 2 Global Next Generation Sequencing Market Drivers: Impact Analysis (2019-2025)
Table 3 Technological Advancements in Next Generation Sequencing
Table 4 Year on Year Sequencing Cost Reduction: 2008-2019
Table 5 Government Initiatives for Sequencing
Table 6 Global Next Generation Sequencing Market Restraints: Impact Analysis (2019-2025)
Table 7 Partnerships and Collaborations Among Manufacturers
Table 8 Portable Sequencer Vs Benchtop Sequencer
Table 9 Global Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 10 Global NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 11 Global NGS Consumables Market Size, by Country/Region, 2017-2025 ($Million)
Table 12 Global NGS Sample Preparation Consumables Market Size, by Type, 2017-2025 ($Million)
Table 13 Global NGS Sample Preparation Consumables Market Size, by Country/Region, 2017-2025 ($Million)
Table 14 Global NGS DNA Extraction and Amplification Consumables Market Size, by Country/Region, 2017-2025 ($Million)
Table 15 Global NGS Library Preparation & Target Enrichment Consumables Market Size, by Country/Region, 2017-2025 ($Million)
Table 16 Global NGS Quality Control Consumables Market Size, by Country/Region, 2017-2025 ($Million)
Table 17 Global NGS Other Consumables Market Size, by Country/Region, 2017-2025 ($Million)
Table 18 Global NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 19 Global NGS Platforms/Instruments Market Size, by Country/Region, 2017-2025 ($Million)
Table 20 Features of Illumina NGS Platforms/Instruments
Table 21 Global Illumina NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 22 Global Illumina NGS Platforms/Instruments Market Size, by Country/Region, 2017-2025 ($Million)
Table 23 Features of MiniSeq Systems
Table 24 Global MiniSeq System Market Size, by Country/Region, 2017-2025 ($Million)
Table 25 Features of NovaSeq Systems
Table 26 Global NovaSeq System Market Size, by Country/Region, 2017-2025 ($Million)
Table 27 Features of NextSeq Systems
Table 28 Global NextSeq System Market Size, by Country/Region, 2017-2025 ($Million)
Table 29 Key Specifications of MiSeq System
Table 30 Global MiSeq System Market Size, by Country/Region, 2017-2025 ($Million)
Table 31 Features of iSeq System
Table 32 Global iSeq System Market Size, by Country, 2017-2025 ($Million)
Table 33 Features of Thermo Fisher Scientific NGS Platforms/Instruments
Table 34 Global Thermo Fisher Scientific NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 35 Global Thermo Fisher Scientific NGS Platforms/Instruments Market Size, by Country/Region, 2017-2025 ($Million)
Table 36 Features of Ion Proton System 
Table 37 Global Ion Proton System Market Size, by Country/Region, 2017-2025 ($Million)
Table 38 Features of Ion PGM System
Table 39 Global Ion PGM System Market Size, by Country/Region, 2017-2025 ($Million)
Table 40 Features of Ion S5 and Ion S5 Xl System
Table 41 Global Ion S5 & S5 Xl Market Size, by Country/Region, 2017-2025 ($Million)
Table 42 Features of PacBio NGS Platforms/Instruments
Table 43 Global Pacific Biosciences NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 44 Global Pacific Biosciences NGS Platforms/Instruments Market Size, by Country/Region, 2017-2025 ($Million)
Table 45 Features of PacBio RS II System
Table 46 Global PacBio RS II System Market Size, by Country/Region, 2017-2025 ($Million)
Table 47 Features of PacBio Sequel System
Table 48 Global PacBio Sequel System Market Size, by Country/Region, 2017-2025 ($Million)
Table 49 Features of Oxford Nanopore NGS Platforms/Instruments
Table 50 Global Oxford Nanopore Technology NGS Systems Market Size, by Country/Region, 2017-2025 ($Million)
Table 51 Global Other NGS Instruments Market Size, by Country, 2017-2025
Table 52 Key Players offering NGS Software
Table 53 Global NGS Software Market Size, by Country/Region, 2017-2025 ($Million)
Table 54 Key Players Providing NGS Services
Table 55 Global NGS Services Market Size, by Country/Region, 2017-2025 ($Million)
Table 56 Global Next Generation Sequencing Market, by Sequencing Type, 2017-2025 ($Million)
Table 57 Global Next Generation Sequencing Market Size for Whole Genome Sequencing, by Country, 2017-2025 ($Million)
Table 58 Global Next Generation Sequencing Market Size for Whole Exome Sequencing, by Country, 2017-2025 ($Million)
Table 59 Global Next Generation Sequencing Market Size for Targeted Genome Sequencing, by Country, 2017-2025 ($Million)
Table 60 Global Next Generation Sequencing Market Size for Other Sequencing Approaches, by Country, 2017-2025 ($Million)
Table 61 Global Next Generation Sequencing Market, by Technology, 2017-2025 ($Million)
Table 62 Global Sequencing by Synthesis (SBS) Market Size, by Country, 2017-2025 ($Million)
Table 63 Global Ion Semiconductor Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 64 Global Sequencing by Ligation Market Size, by Country, 2017-2025 ($Million)
Table 65 Global Single Molecule Real-Time Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 66 Global Nanopore Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 67 Global Other Sequencing Technologies Market Size, by Country, 2017-2025 ($Million)
Table 68 Global Next Generation Sequencing Market Size, by Application, 2017-2025 ($Million)
Table 69 Global Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 70 Global Next Generation Sequencing Market Size for Clinical Applications, by Country, 2017-2025 ($Million)
Table 71 Global Next Generation Sequencing Market Size for Oncology, by Country, 2017-2025 ($Million)
Table 72 Global Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 73 Global Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Country, 2017-2025 ($Million)
Table 74 Global Next Generation Sequencing Market Size for NIPT Testing, by Country, 2017-2025 ($Million)
Table 75 Global Next Generation Sequencing Market Size for Carrier Screening, by Country, 2017-2025 ($Million)
Table 76 Global Next Generation Sequencing Market Size for In-Vitro Fertilization, by Country, 2017-2025 ($Million)
Table 77 Global Next Generation Sequencing Market Size for Newborn Screening, by Country, 2017-2025 ($Million)
Table 78 Global Next Generation Sequencing Market Size for Cardiovascular Diseases, by Country, 2017-2025 ($Million)
Table 79 Global Next Generation Sequencing Market Size for Other Clinical Applications, by Country, 2017-2025 ($Million)
Table 80 Global Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 81 Global Next Generation Sequencing Market Size for Research Applications, by Country, 2017-2025 ($Million)
Table 82 Global Next Generation Sequencing Market Size for Drug Discovery, by Country, 2017-2025 ($Million)
Table 83 Global Next Generation Sequencing Market Size for Agriculture & Animal Research, by Country, 2017-2025 ($Million)
Table 84 Global Next Generation Sequencing Market Size for Other Research Applications, by Country, 2017-2025 ($Million)
Table 85 Global Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 86 Global Next Generation Sequencing Market Size for Clinical Diagnostic Laboratories, by End User, 2017-2025
Table 87 Global Next Generation Sequencing Market Size for Academic Institutes and Research Centres, 2017-2025 ($Million)
Table 88 Global Next Generation Sequencing Market Size for Hospitals & Clinics, 2017-2025 ($Million)
Table 90 Global Next Generation Sequencing Market Size for Pharmaceutical & Biotechnology Companies, 2017-2025 ($Million)
Table 91 Global Next Generation Sequencing Market Size for Other End Users, 2017-2025 ($Million)
Table 92 Global Next Generation Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 93 North America: Next Generation Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 94 North America: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 95 North America: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 96 North America: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 97 North America: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 98 North America: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 99 North America: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 100 North America: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 101 North America: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 102 North America: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 103 North America: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 104 North America: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 105 North America: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 106 North America: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 107 U.S.: Key Macroindicators
Table 108 U.S.: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 109 U.S.: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 110 U.S.: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 111 U.S.: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 112 U.S.: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 113 U.S.: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 114 U.S.: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 115 U.S.: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 116 U.S.: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 117 U.S.: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 118 U.S.: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 119 U.S.: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 120 U.S.: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 121 Canada: Key Macroindicators
Table 122 Canada: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 123 Canada: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 124 Canada: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 125 Canada: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 126 Canada: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 127 Canada: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 128 Canada: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 129 Canada: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 130 Canada: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 131 Canada: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 132 Canada: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 133 Canada: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 134 Canada: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 135 Europe: Next Generation Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 136 Europe: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 137 Europe: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 138 Europe: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 139 Europe: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 140 Europe: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 141 Europe: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 142 Europe: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 143 Europe: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 144 Europe: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 145 Europe: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 146 Europe: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 147 Europe: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 148 Europe: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 149 Germany: Key Macroindicators
Table 150 Germany: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 151 Germany: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 152 Germany: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 153 Germany: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 154 Germany: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 155 Germany: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 156 Germany: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 157 Germany: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 158 Germany: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 159 Germany: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 160 Germany: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 161 Germany: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 162 Germany: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 163 France: Key Macroindicators
Table 164 France: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 165 France: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 166 France: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 167 France: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 168 France: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 169 France: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 170 France: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 171 France: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 172 France: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 173 France: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 174 France: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 175 France: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 176 France: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 177 U.K.: Key Macroindicators
Table 178 U.K.: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 179 U.K.: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 180 U.K.: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 181 U.K.: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 182 U.K.: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 183 U.K.: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 184 U.K.: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 185 U.K.: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 186 U.K.: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 187 U.K.: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 188 U.K.: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 189 U.K.: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 190 U.K.: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 191 Italy: Key Macroindicators
Table 192 Italy: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 193 Italy: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 194 Italy: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 195 Italy: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 196 Italy: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 197 Italy: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 198 Italy: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 199 Italy: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 200 Italy: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 201 Italy: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 202 Italy: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 203 Italy: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 204 Italy: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 205 Spain: Key Macroindicators
Table 206 Spain: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 207 Spain: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 208 Spain: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 209 Spain: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 210 Spain: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 211 Spain: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 212 Spain: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 213 Spain: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 214 Spain: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 215 Spain: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 216 Spain: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 217 Spain: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 218 Spain: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 219 RoE: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 220 RoE: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 221 RoE: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 222 RoE: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 223 RoE: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 224 RoE: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 225 RoE: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 226 RoE: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 227 RoE: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 228 RoE: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 229 RoE: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 230 RoE: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 231 RoE: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 232 Asia-Pacific: Next Generation Sequencing Market Size, by Country, 2017-2025 ($Million)
Table 233 Asia-Pacific: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 234 Asia-Pacific: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 235 Asia-Pacific: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 236 Asia-Pacific: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 237 Asia-Pacific: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 238 Asia-Pacific: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 239 Asia-Pacific: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 240 Asia-Pacific: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 241 Asia-Pacific: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 242 Asia-Pacific: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 243 Asia-Pacific: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 244 Asia-Pacific: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 245 Asia-Pacific: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 246 Japan: Key Macroindicators
Table 247 Japan: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 248 Japan: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 249 Japan: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 250 Japan: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 251 Japan: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 252 Japan: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 253 Japan: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 254 Japan: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 255 Japan: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 256 Japan: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 257 Japan: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 258 Japan: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 259 Japan: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 260 China: Key Macroindicators
Table 261 China: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 262 China: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 263 China: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 264 China: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 265 China: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 266 China: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 267 China: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 268 China: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 269 China: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 270 China: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 271 China: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 272 China: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 273 China: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 274 India: Key Macroindicators
Table 275 India: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 276 India: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 277 India: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 278 India: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 279 India: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 280 India: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 281 India: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 282 India: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 283 India: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 284 India: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 285 India: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 286 India: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 287 India: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 288 RoAPAC: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 289 RoAPAC: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 290 RoAPAC: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 291 RoAPAC: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 292 RoAPAC: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 293 RoAPAC: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 294 RoAPAC: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 295 RoAPAC: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 296 RoAPAC: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 297 RoAPAC: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 298 RoAPAC: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 299 RoAPAC: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 300 RoAPAC: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 301 Latin America: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 302 Latin America: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 303 Latin America: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 304 Latin America: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 305 Latin America: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 306 Latin America: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 307 Latin America: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 308 Latin America: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 309 Latin America: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 310 Latin America: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 311 Latin America: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 312 Latin America: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 313 Latin America: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 314 Middle East & Africa: Next Generation Sequencing Market Size, by Type, 2017-2025 ($Million)
Table 315 Middle East & Africa: NGS Consumables Market Size, by Type, 2017-2025 ($Million)
Table 316 Middle East & Africa: NGS Platforms/Instruments Market Size, by Type, 2017-2025 ($Million)
Table 317 Middle East & Africa: NGS Platforms/Instruments Market Size for Illumina, by Type, 2017-2025 ($Million)
Table 318 Middle East & Africa: NGS Platforms/Instruments Market Size for Thermo Fisher Scientific, by Type, 2017-2025 ($Million)
Table 319 Middle East & Africa: NGS Platforms/Instruments Market Size for Pacific Biosciences, by Type, 2017-2025 ($Million)
Table 320 Middle East & Africa: Next Generation Sequencing Market Size, by Sequencing, 2017-2025 ($Million)
Table 321 Middle East & Africa: Next Generation Sequencing Market Size, by Technology, 2017-2025 ($Million)
Table 322 Middle East & Africa: Next Generation Sequencing Market Size, by Applications, 2017-2025 ($Million)
Table 323 Middle East & Africa: Next Generation Sequencing Market Size for Clinical Applications, by Type, 2017-2025 ($Million)
Table 324 Middle East & Africa: Next Generation Sequencing Market Size for Reproductive Health Diagnostics, by Type, 2017-2025 ($Million)
Table 325 Middle East & Africa: Next Generation Sequencing Market Size for Research Applications, by Type, 2017-2025 ($Million)
Table 326 Middle East & Africa: Next Generation Sequencing Market Size, by End User, 2017-2025 ($Million)
Table 327 Number of Developments by the Major Players During 2016-2019
Table 328 Next Generation Sequencing Market: Competitive Benchmarking

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 NGS Consumables Segment Dominates the Global Next Generation Sequencing Market
Figure 6 Global Next Generation Sequencing Market Size, by Type, 2019-2025 ($Million)
Figure 7 Global Next Generation Sequencing Market Size, by Sequencing Type, 2019-2025 ($Million)
Figure 8 Global Next Generation Sequencing Market Size, by Technology, 2019-2025 ($Million)
Figure 9 Global Next Generation Sequencing Market Size, by Application, 2019-2025 ($Million)
Figure 10 Clinical Diagnostic Laboratories Segment Will Dominate the Global Next Generation Sequencing Market During the Forecast Period
Figure 11 Global Next Generation Sequencing Market Overview, by Region, 2019-2025
Figure 12 Rise in the Number of Personalized Medicines, 2008-2017
Figure 13 Global Next Generation Sequencing Market Size, by Type, 2019-2025 ($Million)
Figure 14 Global Next Generation Sequencing Market, by Sequencing Type, 2019-2025 ($Million)
Figure 15 Global Next Generation Sequencing Market, by Technology, 2019-2025 ($Million)
Figure 16 Global Next Generation Sequencing Market Size, by Application (2019-2025)
Figure 17 New Cancer Cases Globally: 2018-2040
Figure 18 Cardiovascular Diseases Deaths Worldwide (In Millions): 2016 and 2030
Figure 19 Global Rise in the Number of Personalized Medicines, 2008-2018
Figure 20 Global Next Generation Sequencing Market Size, by End User, 2019-2025 ($Million)
Figure 21 Number of Hospitals in U.S.: 2019 and 2016
Figure 22 Number of Pharmaceutical Companies with Active Pipelines: 2012-2019
Figure 23 Global Next Generation Sequencing Market Size, by Region, 2019-2025 ($Million)
Figure 24 North America: Next Generation Sequencing Market Size, by Country, 2019-2025 ($Million)
Figure 25 Number of New Cancer Cases in the U.S., 2012-2030 (Cases in Millions)
Figure 26 Number of Cancer Cases in Canada: 2018-2040
Figure 27 Population Aged 60 Or Over in Europe
Figure 28 Number of Cancer Cases in Europe (In Millions): 2012-2040
Figure 29 Europe: Next Generation Sequencing Market Size, by Country, 2019-2025 ($Million)
Figure 30 Share of Population Aged 65 and Above (As % of Total Population), 2011-2018
Figure 31 Healthcare Spending Per Capita in France, 2011-2017 ($)
Figure 32 Number of New Cancer Cases and Mortality in U.K.:2018-2040
Figure 33 Cancer Incidence in Italy, 2018-2035 (Number of Cases)
Figure 34 Cancer Incidence and Mortality in Spain, 2018-2040 (Number of Cases)
Figure 35 Cancer Incidence by Country: 2018-2040 (Number of Cases)
Figure 36 Per Capita Health Spending by Country, 2017 (In $ PPP)
Figure 37 Cancer Incidence in Japan: 2018-2040
Figure 38 Cancer Incidence in India: 2018-2040
Figure 39 Cancer Incidence in Latin America & Caribbean, 2018-2040 (Number of Cases)
Figure 40 Cancer Incidence in Middle East and Africa: 2012 and 2030
Figure 41 Growth Strategies Adopted by Key Players (2016-2019)
Figure 42 Global Next Generation Sequencing Market Share, by Key Players, 2018 (%)
Figure 43 Illumina, Inc.: Financial Overview (2016-2018)
Figure 44 Agilent Technologies, Inc.: Financial Overview (2016-2018)
Figure 45 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)
Figure 46 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
Figure 47 Qiagen N.V.: Financial Overview (2016-2018)
Figure 48 PerkinElmer, Inc.: Financial Overview (2016-2018)
Figure 49 F. Hoffmann-La Roche AG: Financial Overview (2016-2018)
Figure 50 Pacific Biosciences of California, Inc.: Financial Overview (2016-2018)
Figure 51 Danaher Corporation: Financial Overview (2016-2018)

The global next-generation sequencing (NGS) market is expected to grow at a CAGR of 16.2% from 2019 to reach $10.35 billion by 2025.

Next Generation Sequencing (NGS) is a technology used to determine the sequence of nucleotides in a given DNA sample. It enables sequencing of DNA or RNA in a short time and at cheaper costs. The growth in this market is majorly driven by technological advancements in sequencing procedures, surge in genome mapping programs, and increase in drug discovery platforms demanding NGS technology. Further, increasing number of government initiatives for large-scale genomic sequencing projects and emergence of cloud computing as a potential data management service are boosting the adoption of NGS products.

Surge in genome mapping programs is propelling the growth of the next-generation sequencing market

The plummeting cost of sequencing has enabled governments across the globe to involve genomic analysis as a major part of disease diagnosis and personalized medicine, globally. For instance, in May 2018, public genome research initiatives “Australian Genomics Health Futures Mission” was launched by Australian government. The mission was launched with an investment of about $370 million to expand access to new research capabilities, clinical trials, and technologies for betterment of healthcare sector. Similarly, in December 2017, in China, 100,000 Genomes Project was launched, which intends to sequence the genomes of 100,000 people from different ethnic backgrounds and regions across China to study transformation of population from health to disease, environmental impacts, and to study the interaction between environmental factors and genes.

Moreover, due to increase in genome mapping programs, research on personalized medicine has also increased. In 2016, European Union (EU) launched program Horizon 2020 in 2016, with an investment of $88.5 billion (€80 billion), of which around 10% (~$9 billion) was aimed to develop and support personalized medicine projects. Similarly, in 2016, China announced five-year plan, with an investment of $9 billion (60 billion yuan) for research and development of personalized medicine.                                             

Growing government initiatives for large -scale genomic sequencing projects supports the market growth

Due to NGS capabilities, increasing applications, and growing trend of personalized medicine, the governments are investing in drug development, research, and clinical diagnostics procedures. Some of the examples of large scale-genomic sequencing projects include:

  • In May 2018, Australian government announced the investment of $372 million for over 10 years in its Genomics Health Futures Mission to sequence 200,000 participants.
  • In U.S., American Association for Cancer Research (AACR) announced the launch of a collaborative initiative known as “2020 by 2020” in 2018. The initiative has aimed to sequence both tumor and normal tissue from 2,020 African-American patients to improve understanding of cancer in African-American population.
  • In 2018, Canadian Institute of Health Research in collaboration with Genome Canada (a non-profit organization using genomic-based technologies) announced an investment of $162 million over a period of 4 years to support 15 genome-based precision health projects.

next-generation sequencing (NGS) market

Click here to: Get Free Sample Pages of this Report

Key Findings in the Global Next-Generation Sequencing Market Study:

Targeted sequencing to witness the largest demand through 2025

Targeted sequencing segment is estimated to command the largest share of global next-generation sequencing technologies market in 2019, due to capability of the technique to call variants, its low sequencing costs as compared to other sequencing technologies, and ability to generate manageable data volumes with reliable results.

Sequencing by Synthesis to register the fastest growth in the next-generation sequencing market by 2025

On the basis of technology, Sequencing by Synthesis segment is estimated to command the largest share of the overall next-generation sequencing market in 2019 and is slated to grow at the fastest CAGR during the forecast period. The large share of this segment is attributed to high accuracy of SBS technology in DNA sequencing, highest yield of error free throughput, and growing incorporation of this technology in NGS instrumentation. Availability of large number of products with SBS technology and launch of products based on SBS technology supports the market growth.

Clinical applications to register the fastest growth in the next-generation sequencing market by 2025

On the basis of application, clinical applications form the largest segment of the global next-generation sequencing market, mainly due to growing incidence of cancer and increasing volume of diagnostic procedures and treatment rates for the disease.According to World Health Organization, International Agency for Research on Cancer (IARC), in 2018, 18.1 million new cancer cases were reported, which is expected to increase to 24.1 million cases by 2030 and 29.5 million new cases by 2040. Therefore, the demand for cancer treatment, associated medicines, and genetic analysis procedures to detect abnormalities in gene expression and function is increasing, ultimately boosting the market for next-generation sequencing technologies.

Clinical Diagnostic Laboratories to dominate global Next-Generation Sequencing Market

On the basis of end-user, clinical diagnostic laboratories segment is estimated to command the largest share of the overall next-generation sequencing market in 2019. Rising pool of cancer patient population visiting diagnostic laboratories for diagnosis & treatment owing to easy accessibility is driving the growth in next-generation sequencing market for this end user segment. Improving healthcare infrastructure across both developed and developing countries also supports the growth of next-generation sequencing market for clinical diagnostic laboratories.

Asia-Pacific: The fastest-growing regional market

North America is estimated to command the largest share of the global next-generation sequencing market in 2019, followed by Europe, Asia-Pacific, Latin America, and Middle East & Africa. However, Asia-Pacific region is expected to register the fastest growth during the forecast period, owing to accelerated economic growth of many countries in this region; growing cancer incidence; and rising focus of governments towards improvement of healthcare sector. In addition, government initiatives and investments in large-scale genome sequencing projects to design targeted medicines are the other key factors propelling the growth of the Asia-Pacific next-generation sequencing market.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2016-2019). The key players profiled in the global next-generation sequencing market report are Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Qiagen N.V. (Netherlands), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), 10X Genomics, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies Ltd (U.K.), Beckman Coulter, Inc. (U.S.), GenapSys, Inc. (U.S.), New England Biolabs, Inc. (U.S.), PierianDx (U.S.), and BGI Genomics (China).

Scope of the Report:

Next-Generation Sequencing Market, by Type

  • Consumables
    • Sample Preparation Consumables
      • DNA Fragmentation & Amplification
      • Library Preparation & Target Enrichment
      • Quality Control
    • Other Consumables
      (Note: Other consumables include vials, pipettes, containers, trays, tubes, and more)
  • NGS Platforms/Instruments
    • Illumina NGS Platforms/Instruments
      • MiSeq Series
      • NextSeq
      • MiniSeq
      • NovaSeq
      • iSeq
    • Thermo Fisher Scientific NGS Platforms/Instruments
      • Ion PGM
      • Ion Proton
      • Ion S5 & S5XL
    • Pacific Biosciences NGS Platforms/Instruments
      • PacBio RS II
      • Sequel systems
    • Oxford Nanopore NGS Platforms/Instruments
    • Others
      (Note: Other instruments used during NGS include PCR systems, automated liquid handling systems, electrophoresis devices, library preparation devices, and more)
  • Software
  • Services

Next-Generation Sequencing Market by Sequencing Type

  • Whole Genome Sequencing
  • Whole Exome Sequencing
  • Targeted Sequencing
  • Others
    (Note: Other sequencing approaches include RNA sequencing, de-novo sequencing, degradome sequencing, miRNA sequencing, chromatin immunoprecipitation (ChIP) sequencing, and methylation sequencing)

Next-Generation Sequencing Market, by Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • Sequencing by Ligation
  • Single-Molecule Real-Time Sequencing
  • Nanopore Sequencing
  • Others
    (Note: Other sequencing technologies include Polony sequencing, pyrosequencing, DNA nanoball sequencing, and true Single Molecule Sequencing (tSMS))

Next-Generation Sequencing Market, by Application

  • Clinical Application
    • Oncology
    • Reproductive Health Diagnostics
      • Non-Invasive Pre-natal Testing
      • Carrier Screening
      • In-Vitro fertilization
      • Newborn Screening
    • Cardiovascular
    • Others
      (Note: Other clinical applications include detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food borne illness)
  • Research Application
    • Drug Discovery
    • Agriculture & Animal Research
    • Others
      (Note: Other research applications include food microbiology, microbiota analysis in beverage industry, and environmental studies)

Next-Generation Sequencing Market, by End User

  • Clinical Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Others
    (Note: Other end-users include forensic departments, food companies, and hospitals)

Next-Generation Sequencing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • India
    • Japan
    • Rest of APAC (RoAPAC)
    • Latin America
  • Middle East & Africa

Key questions answered in the report-

Growing technological advancements in sequencing procedures will propel the next-generation sequencing market

  • How do the advancements in sequencing technologies influence the adoption of NGS products?
  • How are the leading players incorporating the technological developments in their products?

Clinical diagnostic laboratories accounted for the largest share of the next-generation sequencing market

  • What factors are contributing to the frequent usage of next-generation sequencing products in clinical diagnostic laboratories?
  • Which NGS products are commonly used in clinical diagnostic laboratories and are preferred by most of the patients & healthcare professionals?
  • How does the penetration of next-generation sequencing products in clinical diagnostic laboratories differ from other end users?

The North American Next-Generation Sequencing market favors both larger and local manufacturers that compete in multiple segments

  • Who are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What are the major drivers, restraints, opportunities, challenges, and trends in the global next-generation sequencing market?
  • Who are the major players in various countries and what share of the global market do they hold?
  • What are the geographical trends and high growth regions/countries?

Recent new product launches, product enhancements, M&As, and partnerships & collaborations are shaping the competitive landscape of the Next-Generation Sequencing market.

  • Who are the major players in the global next-generation sequencing market and what share of the market do they hold?
  • What are the local emerging players in the global next-generation sequencing market and how do they compete with the global players?
  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the next-generation sequencing market?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: next generation sequencing market Healthcare
Download Free Sample